LAB FY 2008 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$370M

FY 2008 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$15M+111.0% YoY

Gross Profit

$7M45.5% margin

Operating Income

-$30M-192.5% margin

Net Income

-$29M-192.2% margin

EPS (Diluted)

$-17.85

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$30M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$32M

Total Liabilities

$191M

Stockholders' Equity

-$158M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$7M	+111.0%
Gross Profit	$7M	$4M	+85.7%
Operating Income	-$30M	-$24M	-25.6%
Net Income	-$29M	-$25M	-15.9%